RALLYBIO CORPORATION Lessee, Operating Lease, Liability, Undiscounted Excess Amount
RALLYBIO CORPORATION (RLYB) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $14.00 thousand as of 2025-12-31, per its S-4/A filed 2026-08-26.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-26
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $31.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $14.00K S-4/A · filed 2026-08-26 |
| 2024-12-31 | $2.00K 10-K · filed 2025-03-13 |
| 2023-12-31 | $14.00K 10-K · filed 2024-03-12 |
| 2022-12-31 | $31.00K 10-K · filed 2023-03-06 |
| 2022-09-30 | $36.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $44.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $49.00K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |